# Soy Peptide, Conjugated Linoleic Acid, Overweight or Obese, Body Composition

> **NCT04728399** · NA · UNKNOWN · sponsor: **Fangfang Zeng** · enrollment: 120 (estimated)

## Conditions studied

- Overweight or Obesity

## Interventions

- **DIETARY_SUPPLEMENT:** Experimental group
- **DIETARY_SUPPLEMENT:** Control group

## Key facts

- **NCT ID:** NCT04728399
- **Lead sponsor:** Fangfang Zeng
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-05-14
- **Primary completion:** 2022-12-20
- **Final completion:** 2022-12-20
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2021-06-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04728399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04728399, "Soy Peptide, Conjugated Linoleic Acid, Overweight or Obese, Body Composition". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04728399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*